Indaptus Therapeutics, Inc.
INDP · XNASCIK 1857044fmd_0KJTP5NNYPN9FB9G4DPVPPCRX4Manufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2020 to Jun 30, 2026, 26 periods
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Research and development | 3 | 3 | 6 | 8 | 7 | 9 |
| Total operating expenses | 4 | 8 | 15 | 16 | 15 | 20 |
| Operating income | (4) | (8) | (15) | (16) | (15) | (20) |
| Other non-operating income (expense) | 0 | 0 | 1 | 1 | 0 | – |
| Income before taxes | – | – | – | – | (15) | (21) |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | – | – | – | (15) | (21) |
| Net income | (4) | (8) | (14) | (15) | (15) | (21) |